#Max Hospital Delhi Email Address

[healthcare-tourism-india]

Choosing Max Hospital for Orthopedic Surgery: A Wise Decision

Max Hospital best orthopaedic surgery in India employs the latest minimally invasive techniques that lead to quicker recovery times and better outcomes for patients.

[lisaoshiola]

Innovations in Radiation Oncology: Insights from Dr. Hukku

It is important to recognize that approximately two-thirds of individuals diagnosed with cancer require radiation therapy in order to achieve remission.

[wemedicalcare]

Dr. Vijendra Kumar Jain ( Neurosurgeon in India )

MBBS, MCh – Neuro Surgery

Neurosurgeon, Spine Surgeon, 41+ Years of Experience

( Best Neurosurgeon and Spine Surgeon in India )

Dr. V K Jain is the Principal Director of Neurosurgery and Spine Surgery at Max Hospitals in Delhi and NCR.

Dr. Vijendra Kumar Jain is one of India’s best neurosurgeons and spine surgeons. He is the head of Max Hospitals’ Neuro and Spine Department in Delhi and the NCR region. He has over 41 years of experience in Neurosurgery. He is the most recommended neurosurgeon in India by patients. He has performed over 16,000 procedures and is recognized for his expertise and skill in the field.

ADDRESS:

Max Super Speciality Hospital, Saket Institutional Area, Saket, New Delhi, Delhi 110017, India

EMAIL ADDRESS:

vkjneuro@gmail.com

PHONE NO:

+91-099-107-74433

Tag = Spine Surgeon in India, Neurosurgeon in India

[neurosurgeondelhi]

DR. VIJENDRA KUMAR UTILIZES ADVANCED NEUROSURGICAL PROCEDURES AT AN AFFORDABLE COST IN NEW DELHI

Dr. Vijendra Kumar Jain has been working as a neurosurgeon for over 41+ years in India. He is widely acknowledged for his skills and techniques in the fields of neurosurgery and spine surgery.

Neurosurgeon, Dr. Vijendra Kumar Jain offers advanced neurosurgical procedures at an affordable cost  in New Delhi. He is a neurosurgeon who performs intraventricular tumor surgery in India for over 41 years. The surgery was performed at one of the private hospitals with comprehensive equipment in New Delhi. Dr. Vijendra Kumar Jain has all the ultra modern equipment and can perform the surgery to treat any brain or spinal cord disease. Moreover, Dr. Jain has performed 16,000 successful operations on children and adults. He completed his training at the King George’s Medical College, Lucknow, and achieved a fellowship in Micro-neurosurgery at Fujita Health University, Nagoya, Japan. Dr. Jain is also a member of many medical association such as the Neurological Society of India, the Indian Society of Paediatric Neurosurgery, the Indian Society of Cerebrovascular Surgery, the Asian-Australasian Society of Neurological Surgeons, the Society of Pharmacovigilance (India), and many more.

For the past decades, Dr. Vijendra Kumar Jain has been at the forefront of innovation in Cerebrovascular surgery in India. His numerous innovations have made it possible to cure patients of inoperable brain tumors. As a result, there has been a significant decrease in mortality rates for people who have been diagnosed with brain cancer.

Dr. Jain specializes in brain tumor surgeries, which include:

– Intraventricular Tumor Surgery

– Cerebrovascular Surgery

– Brain Tumor Surgery

– Spine Surgery

– Spinal Instrumentation

Dr. Jain has been practicing medicine in India for over four decades, assisting people who cannot otherwise afford quality health care. He founded the Neurosurgery and Spine Surgery Center in New Delhi, India, which has performed thousands of successful surgeries on patients who were previously told their condition was incurable. Dr. Jain is also the Principal Director of Neurosurgery and Spine Surgery at Max Hospitals in Delhi and National Capital Region. Moreover, he has published several research papers and publications, including “Craniovertebral Junction Anomalies – The Indian Experience,” published in 1997.

About the Neurosurgeon

Dr. Vijendra Kumar Jain is a renowned neurosurgeon in India. He specializes in minimally invasive endovascular neurosurgery. He has performed thousands of successful complex brain surgeries using techniques like minimally invasive endovascular neurosurgery, intraoperative MRI monitoring, functional mapping during surgery, and stereotactic radiosurgery (SRS). Intraventricular tumor surgery in India with Dr. Vijendra Kumar Jain is a practical choice for those looking to avoid the risks of major brain surgery and hoping to maintain a high quality of life. For more information on the procedure, location, or any other process aspects, please visit http://www.brainspineneurodelhiindia.com.

Media Contact Company Name:         Neurosurgery and Spine Surgery Contact Person:          Dr. Vijender Kumar Jain Email:                          vkjneuro@gmail.com Phone:                         +91-9910774433S Address:                       Max Super Speciality Hospital, aket Institutional Area, Saket City:                             New Delhi State:                            Delhi Country:                      India Website:                       https://www.brainspineneurodelhiindia.com

TAG : Spine Specialist in India, Best Brain Tumor Surgeon in India, Spine Surgeon in India, Best Spine Surgeon in India

[drvijenderkumarjain]

Get an appointment with Dr. V K Jain Best Spine Surgeon/Neurosurgeon in India

Dr. V K Jain is the Principal Director of Neurosurgery and Spine Surgery at Max Hospitals in Delhi and NCR.

Dr. Vijender Kumar Jain is one of the best neurosurgeons and spine surgeons in India. He is the head of Max Hospitals' Neuro and Spine Department in Delhi and NCR region. He has over 41 years of experience in Neurosurgery. He is the most recommended neurosurgeon in India by patients. He has performed over 16,000 procedures and is recognized for his expertise and skill in the field.

He is known for his surgical precision and his expertise lies in treating tumors, aneurysms, spinal cord injuries, and other conditions related to brain and spine. Patients from all over the world travel to India to seek his expertise in neurosurgery. Dr. Jain's passion for clinical work and his training as well as research allow him to be a standout neurosurgeon in India. He has penned a substantial number of papers in peer-reviewed journals and has been a keynote speaker at several medical conferences. His research and innovative surgical techniques have earned him well-deserved repute in the medical field

Work Experience

41 years of experience in Neurosurgery

Currently, Principal Director at Department of Neurosurgery at Max Hospitals in Delhi and NCR region

Chairman of the Neurosurgery Department, Sir Ganga Ram Hospital, since February 2010

Prof. at SGPGIMS, Lucknow, from Apr 1999 to Feb 2010

Visiting Professor at University Hospital of Geneva, Geneva, Switzerland from 15th to 30th June 2001

Visiting Professor at Fujita Gakuen Health University, Toyoake, Aichi, Japan from 03.05.1999 to 29.05.1999

Additional Prof. at SGPGIMS, Lucknow, September 1987 to April 1999

Associate Prof. at NIMHANS, Bangalore, December 1984 to September 1987

Assistant Prof. at NIMHANS, Bangalore, September 1981 to December 1984

Contact us

ADDRESS:

Max Super Speciality Hospital, Saket Institutional Area, Saket, New Delhi, Delhi 110017, India

EMAIL ADDRESS:

vkjneuro@gmail.com

PHONE NO:

+91-099-107-74433

Tags=  Spine Surgeon in India, Neurosurgeon in India, Best Neuro Surgeon in India,  Neurologist in India, Best Brain Tumor Surgeon in India,  Best Spine Surgeon in India

[onlineupssupplier]

Top 10 Online UPS Suppliers - Delhi - ABP Powers

ABP Powers are the main makers, providers and exporters of the Online UPS Suppliers. It is the best item which is generally utilized in homes and in IT firms. It gives assurance against information misfortune because of influence cuts. The Online UPS cost range shifts with the item range which begins from 600VA UPS to 10KVA Online UPS. It is the best item to give security to PCs from information misfortune and information debasement.

Power is your Business Life Line. The more you have the better for your business development and efficiency and losing it might demonstrate awful for your business. Thus, for continuous power security and execution save it with ABP online ups framework. The online ups cost range is very reasonable and shifts according to the necessity. Our objective of zero deformities and complete consumer loyalty makes us the favoured provider for the overwhelming majority of significant organizations in the gadgets and data enterprises. At, our quality is estimated by our items.

Address:- 8th floor HB TWIN TOWER

Netaji Subhash Place

Above Max Hospital

Delhi 110034

Ph:- +91-9811143019

Email Id:-sales@abppowers.com, ajay@abppowers.com

[areyouhealthy]

Max Super Speciality Hospital, Shalimar Bagh

Max Super Speciality Hospital, Shalimar Bagh

Business Name/ Practictioners Name Max Super Speciality Hospital, Shalimar Bagh Address Max Super Speciality Hospital, C and D Block, Shalimar Place Site, Shalimar Bagh, New Delhi, Delhi, 110088, India Phone 01166000000 Email wecare@maxhealthcare.com

[lisaoshiola]

Pediatric cardiology is a specialized field within pediatrics that focuses on the diagnosis and management of heart conditions in children.

[neurosurgeondelhi]

DR. VIJENDRA KUMAR JAIN HAS SUCCESSFULLY PERFORMED 16,000 SURGERY IN INDIA

Dr. Jain has treated several patients suffering from brain tumors, such as Astrocytomas, Oligodendroglioma, Ependymoma, and Medulloblastoma, among others, with a high success rate of up to 85 percent.

Dr. Vijendra Kumar Jain is a reputed Brain Tumor Neurosurgeon in India who has been practicing for the past 41 years after completing his training at prestigious institutes in India and Japan. Dr. Jain has been performing high-risk Brain Tumor Surgery in India for benign and malignant tumors of the brain, spinal cord, pituitary gland, and other areas with a reasonable success rate and minimal mortality rate. He is one of India’s most sought-after neurosurgeons, having performed over 16,000 surgeries with minimal mortality rate. This experience gives him an edge over the competition in treating patients suffering from this condition.

Dr. Vijendra Kumar Jain practises in one of the best brain tumor treatment centers in India due to the high experience of the doctors, state-of-the-art technology, excellent infrastructure, and support staff. In addition, they are well equipped with all the sophisticated medical facilities required for successful brain surgery. Dr. Vijendra Kumar Jain has a team of highly qualified and expert surgeons as well as nursing staff. They have been performing brain tumor surgery for years and have performed thousands of successful brain tumor surgeries. Their surgeon, Dr. Vijendra Kumar Jain, is one of India’s best brain tumor surgeons. Dr. Vijendra Kumar Jain and staff deal with all kinds of diseases, disorders, injuries, and accidents affecting the brain.

Dr. Vijendra Kumar Jain has devoted his career to treating patients with brain tumors and other nervous system disorders in India and across the world. He has established himself as one of the leading Indian neurosurgeons dealing with complex cranial, spinal and peripheral nerve surgery cases, working closely with international surgeons to treat global patients properly.

“The best brain tumor surgeon in India, Dr. Vijendra Kumar Jain has the medical know-how and training to diagnose and treat tumors and other conditions of the brain. He can perform minimally invasive procedures, which have fewer risks and faster recovery time than traditional surgeries.” Said a staff of Dr. Vijendra Kumar Jain.

About Dr. Vijendra Kumar Jain

Dr. Vijendra Kumar Jain is a reputed Neurosurgeon in India with over 16,000 surgeries and a high successful rate. He is considered among the Top Brain Tumor Surgeons in India by his peers and is known for his expertise in handling complicated cases of Brain Tumor Surgery. He also has a dedicated team of surgeons and support staff who work hard to keep the patients comfortable and relaxed during their stay at the hospital and provide them with the best care possible. For more information, please visit https://www.brainspineneurodelhiindia.com.

Media Contact

Company Name:        Neurosurgery and Spine Surgery Contact Person:         Dr. Vijender Kumar Jain Email:                         vkjneuro@gmail.com Phone:                         +91-9910774433 Address:                      Max Super Speciality Hospital, Saket Institutional Area, Saket City:                            New Delhi State:                           Delhi Country:                     India Website:                      https://www.brainspineneurodelhiindia.com

TAG : Best Spine Surgeon in India, Neurosurgeon in India, Neurologist in India, Best Brain Tumor Surgeon in India, Spine Surgeon in India

[bestsurgeonsinindia-blog]

Dr. V. K. Jain best neurosurgery doctor in India offers the highest level of patient care provided to treat patients with a variety of neurological disorders ranging from the common to the most complex. He uses the ultra-modern improvements in imaging technology to diagnose and expand individualized treatment plans providing the best consequences for our patients. He is dedicated to bringing holistic services to patients of every age, with an emphasis in prognosis, treatment, prevention and rehabilitation.

[brajeshupadhyay]

Nearly two months after Delhi govt caps COVID-19 treatment prices, patients complain of overcharging by private hospitals

On 20 June, the Delhi government issued an order capping prices for COVID-19 treatments in private hospitals “with the proviso that all COVID-19 beds would be at rates given by the committee (formed under NITI Aayog member Dr VK Paul) subject to upper limit of 60 percent of the beds of total hospital bed capacity".

According to the order, the prices for all National Accreditation Board for Hospitals & Healthcare Providers-accredited hospitals were to be capped at Rs 10,000, Rs 15,000, and Rs 18,000 for isolation beds, ICU beds without ventilators, and with ventilators support, respectively.

Similarly, for all non-NABH accredited hospitals, the prices were Rs 8,000, Rs 13,000, and Rs 15,000, respectively.

The order clarified further: "The rates for private hospitals beds would be all inclusive as a package. This will include, but not limited to: bed, food and other amenities, monitoring, nursing care, doctors' visits/ consults, investigations including imaging, treatment as per the national protocol for COVID-19 care and standard care for co-morbidities, oxygen, blood transfusion, etc.”

Despite the order, private hospitals have continued to not only violate the norms, as the following case studies show, they have often been kept in dark about the scheme.

The authorities, for their part seem reluctant to fix the flaws in the government order or take the violators to task as issues remain despite repeated interventions from civil society organisations.

Caught between insurance provider, hospital

On 20 June, 60-year-old Tarun Lata was admitted to Shri Moolchand Kharaiti Ram Hospital and Ayurvedic Research Institute, a NABH-accredited facility for COVID-19 with left side pneumonia and pleural effusion. After being kept in an isolation ward for 10 days, Lata was billed Rs 2,59,348.

The hospital bill included an average cost of PPE kits at Rs 4,477 per day and oxygen charges for nine days at the rate of Rs 1,400 per day even though she was not even administered oxygen.

When Lata's son Nitin Gulati objected to the bill and asked the hospital to charge as per the rates fixed by the Delhi government, the hospital claimed the order was passed a day after Lata was admitted to the hospital.

His father and brother also tested COVID-19 positive and were under home isolation.

“It was a very traumatic situation for me, running between my mother in hospital and two other family members at home, and then there was this fiasco with the hospital,” said Gulati.

On 8 August, when I spoke to people in the cash counter and the admission department, and the billing department, they said that Lata’s case was to be charged under insurance and not the Delhi government price capping.

The front desk executive then called back to give me email addresses to write to.

“Please send us your queries again. Our senior team will have to discuss and revert accordingly,” the executive said.

In the meantime, the hospital had already sent a response on the case on 7 August denying these charges.

Dr Madhu Handa, medical administrator, wrote that the billing was done as per the agreement between the hospital and the insurance company.

The Delhi government order, however, lays down no special exceptions for insurance cases.

Gulati explained that he sought help from the corporate insurance cover provided by his employer.

He says that there was a tussle between the hospital and the insurance company over the bill. At first, the insurance company had said that they would pay as per the Delhi government price capping only, and refused to adhere to the full billing, informed Gulati.

The hospital, however, refused to budge. As a result, the insurance covered only Rs 1.02 lakh of the bill. After Gulati's employer approached the insurance company, an additional Rs 80,000 was added to the amount covered.

“That still meant an out of pocket expenditure of Rs 80,000. But, the larger issue is that the hospital never bothered to inform us properly about the Delhi government price capping, let alone implement it,” said Gulati.

Lata's is not the only case involving overcharging by Delhi hospitals, though.

Representational image. AP

Selective redressal 

Nitin Kumar, 22, had to take up against three different hospitals: Max Super Speciality Hospital Saket (East Block), Goyal Hospital and Urology Centre, and Max Smart Super Speciality in Saket over rampant overcharging.

He and his mother Binney Rani tested COVID-19 positive while the rest of their family was in isolation.

"It was difficult to continue challenging the hospitals in that situation,” he said.

Kumar noted that he was administered FabiFlu at Max Super Speciality Hospital without his informed consent.

“Even though I consumed FabiFlu for only two days (26 tablets in total), I have been charged for two boxes of the medicine (34 tablets each). I was not given any of the medicine to take home when I was discharged,” he said, adding that he had been charged Rs 6,998.

“This was all via Whatsapp!” he added and recalled that he repeatedly refused to give consent to these practices of the hospitals.

Additionally, he had also been charged for medicines and investigations that are a part of the standard care for COVID-19 patients at Rs 2,185.50 and Rs 8,850, respectively.

Kumar’s grievances with Max Super Speciality Hospital were drafted and sent as a complaint letter to the hospital authorities as well as members of the state and central health departments.

In fact, on 1 August, Arti Ahuja, additional secretary (MoHFW) forwarded Nitin’s petition against Max Super Speciality Hospital to Vikram Dev Dutt, principal secretary (Delhi HFW) urging him to "enquire into the matter and take appropriate action".

Thereafter, the hospital took cognisance of this and refunded the overbilled amount. The hospital asked him to sign a non-disclosure agreement, which he had reservations against doing and thus only gave only a written acknowledgement instead.

The complaints regarding Kumar's mother’s treatment charges at Max Smart Super Speciality Hospital, Saket (East Block) and Goyal Hospital and Urology Center, however, have still not been acknowledged.

She was overbilled Rs 75,947 at Max Smart, and Rs 28,000 on a COVID-19 package along with an arbitrary pricing of Rs 4,000 for ambulance transfer at Goyal Hospital.

On 30 July, when this author spoke to Shaleen Mitra, the OSD to Delhi health minister Satyendar Jain, he was not aware of these complaints sent to his department and requested that these be forwarded to him again.

On 4 August, Mitra replied that “Nitin's payment was returned by the hospital”. However, he gave no acknowledgement of the complaints about overcharging in Nitin's mother's medical bills.

Tanushree Roy Chowdhury, the deputy general manager, corporate communications and public relations of Max Healthcare, initially said the complaint was resolved.

Then on 1 August, Chowdhury replied again saying she would look into the matter after the 'long weekend'. There has been no response.

Pay or take the patient out

Mayanka Sanghotra’s mother Narender Kaur breathed her last on 17 July in Shanti Mukand Hospital. Kaur was admitted there since 24 June after being diagnosed as COVID-19 positive. This hospital too didn't inform Mayanka of the government orders, and asked her to pay for a COVID-19 package of Rs 4 lakh instead.

Later, she was asked to procure three injections costing Rs 40,000 each and six vials of remdesiver which is really not easy to find.

“When I went to search for remdesiver outside, there was so much blackmarketing happening! The prices ranged from Rs 30,000 to Rs 80,000. And, the doctors had asked for six vials of the medicine,” she said.

Malini Aisola from All India Drugs Action Network (AIDAN) said, "The (20 June) order does mention an exclusion from the rate caps for experimental therapies such as remdesivir and tocilizumab which can be charged separately. Similarly, the IL-6 test and COVID-19 diagnostic test are also excluded from the package rates. However, in spite of the order, hospitals have been tacking on charges for both medicines routinely used in COVID-19 treatment and for investigations and baseline tests that should have been included in the package. We have observed these violations repeatedly and in numerous private hospitals.”

When Mayanka was informed that the bills had exceeded Rs 7.5 lakh by 5 July, she was worried. She looked around for help and managed to contact Amresh Kumar, the Aam Aadmi Party, as well as Malini.

When conversations did not seem to yield results, she wrote a complaint letter on 11 July. On 14 July, when she went to speak to the authorities about the complaint, Malini accompanied her.

Dr Tejender Pal, a physiotherapist, and Dr Samrul Hoda, from the billing department, said that that these escalations would make no difference.

Mayanka claims that on On 17 July, Dr Hoda told her on a phone call to “either arrange the payment" or she could "take the patient out of this hospital".

Later that day, Mayanka received another call from the billing department saying that the hospital has finally agreed to revise her bills according to the government capping. The issues in her mother's medical bills were settled, but two hours later, the hospital informed Mayanka that her mother's condition was unstable. Kaur was declared dead by 9.30 pm that night.

On 26 July, the hospital directed this reporter to Dr Hoda for a statement about the overbilling in this case, however, he said that he couldn't discuss the details.

He further added that he does not particularly remember this case, and did not have access to the records as it was a weekend. He promised to get in touch with further details later.

On 7 August, he informed that he was not authorised to talk about these things, but still explained: "The patient had agreed to pay the hospital rates and was not admitted as a government category. It might have happened that they ran out of money later, and hence started saying that they want the government prices.”

He also informed that though a certain undertaking exists, access to that document is restricted to me as well as the patient’s family.

“It is a hospital document, after all. We can only hand it to authorised persons,” he said.

Representational image. AP

Month after order, issues remain

On 23 June, several CSOs including AIDAN, Jan Swasthya Abhiyan (JSA), and twenty five others wrote to authorities welcoming the order capping prices for COVID-19 treatments and suggested immediate action points.

The capping restriction to only 60 percent of the beds seemed “arbitrary and incomprehensible” to them, and they suggested that this provision be extended to “all persons accessing treatment through private hospitals, and who are not covered under any laws or schemes that guarantee free treatment."

They also said that the order must apply to all COVID-19 patients including those who currently admitted and undergoing treatment in private hospitals.

In a press conference on 25 July, Inayat Singh Kakar of People's Health Movement noted that there has been no transparency or political will to implement the order.

On 25 July, these CSOs also organised a virtual press conference highlighting the continued violations of the order by private hospitals. They released another letter that��highlighted problems in implementation and suggested remedial measures to the authorities.

The above mentioned testimonies are just the tip of the iceberg. More than a month after the order was passed and subsequent interventions from the CSOs, issues remain.

Crumbling infrastructure 

According to the National Health Accounts estimates, released in March 2019, patients in India bear about 61 percent of the total health expenditure. The government’s health expenditure stands at an abysmally low 30.6 percent.

The Economic Survey 2020 shows that the government expenditure on healthcare was 1.6 percent in FY20 budget, a minuscule change from 1.5 percent in FY19. The National Health Policy, 2017, has recommended that health expenditure by the government should be 2.5 percent of GDP by 2025.

A 2018 study which analysed the financial burden of households’ out-of-pocket payments on medicine in India over a period of 2o years between 1994 and 2014 found that 3.8 crore Indians fell below the poverty line due to spending on medicines alone.

Jashodhara Dasgupta, from Sahayog, a non-profit voluntary organisation, explained how the term "out of pocket expenditure" concealed quite a few crucial facts about medical costs in India.

“Our public healthcare is immensely under-resourced and almost dysfunctional. In contrast, the private hospitals do have substantially more resources — both in terms of infrastructure as well as number of doctors. In times of a crisis like the pandemic, the people will be compelled to go to private hospitals,” she says.

Dasgupta informs that private hospitals function primarily with the support of private insurance and State-funded insurance companies, which allows them to hike prices astronomically.

She lays out two scenarios: “You see, when a minister gets admitted in a private hospital, the government covers the costs of that treatment, right? We, the taxpayers, pay for the  treatment in private hospitals. The second situation is when corporate employees or PSU employees go to private hospitals, there’s the safety net of employer paid insurance. Concurrently, in both the cases, private hospitals use this to their advantage and their prices are hiked up astronomically.”

While the Delhi government did put together an order to contain some of the issues plaguing the private healthcare sector, the political will to implement it seems to be lacking.

When Amresh was approached about Mayanka’s case on 6 August, he said that he has followed the usual process of putting the patient in touch with the DMS of the hospital.

While that is an essential step, it  still leaves the patient trying to fight for his or her rights against the hospital.

via Blogger https://ift.tt/3gJTlGn

[ladystylestores]

Shaky Reopenings, Boris Johnson, Coronavirus: Your Thursday Briefing

(Want to get this briefing by email? Here’s the sign-up.)

Good morning.

We’re covering what reopenings look like in countries with rising coronavirus cases, Boris Johnson’s response to the U.S. protests and answers to a decades-old Swedish murder mystery.

Shaky reopenings in countries with virus problems

India has more new daily coronavirus infections than all but the United States and Brazil. But, ready or not, much of India’s lockdown has ended, as have those in other countries struggling to balance economic damage with coronavirus risk.

Some leaders, especially in the developing world, said they couldn’t sustain the punishing lockdowns without risking economic catastrophe for their poorest citizens.

Our correspondents looked at the reopening in India and four other countries — Russia, Iran, Pakistan and Mexico — whose leaders have prioritized restarting even with rising coronavirus cases.

Russia: The country is adding 8,000 to 9,000 new infections each day; even so, Moscow’s mayor lifted many restrictions on Tuesday. One reason, analysts say, is to encourage turnout at a July 1 referendum that could allow President Vladimir V. Putin to remain in power until 2036.

India: In New Delhi, an already strained public health care system may be reaching a breaking point. People can’t get tested. And government officials, desperate for hospital beds, proposed turning the city’s fanciest hotels into health centers.

Iran: Iran, an early epicenter of the global pandemic, reopened in early May to salvage its economy. It’s now seeing a second surge; experts reported 3,574 new infections on June 4, the highest number of new cases since the coronavirus crisis began.

Boris Johnson’s response to Britain’s racism

At a time when the unrest in the United States is prompting many Britons to examine their own society’s racial injustice, Prime Minister Boris Johnson is still struggling to find his voice.

Mr. Johnson was late to address the protests in London and other cities after George Floyd’s death. He has oscillated between calls for law and order and promises to listen to black Britons.

Erdogan and Trump form new bond

Relations between President Trump and President Recep Tayyip Erdogan of Turkey were in the worst state in recent memory 10 months ago — heading toward clashes between their armies across the Syrian-Turkish border.

But as the coronavirus threatens recession and rallies their opponents, the two leaders are finding a common cause — for now. On Monday, they shared a few jokes during a phone call, according to Turkey.

“To be honest, after our conversation tonight, a new era can begin between the United States and Turkey,” Mr. Erdogan said afterward.

Details: In recent months, Mr. Trump has even assisted Turkey’s interventions in Syria and Libya. He also did not impose sanctions on Turkey for its purchase of a Russian S-400 missile system, which has helped Turkey stay closer to the West.

Also: President Volodymyr Zelensky of Ukraine won an endorsement for his anti-corruption policies with the approval of a $5 billion lending program from the International Monetary Fund.

If you have 5 minutes, this is worth it

Russia’s oil spill spreads toward the Arctic Ocean

Here’s what else is happening

Sweden: The country’s judiciary has finally named a man who they believe assassinated Prime Minister Olof Palme on a quiet Stockholm street in 1986. A prosecutor said “reasonable evidence” pointed to Stig Engstrom, a graphic designer, who took his own life in 2000 at the age of 66.

Brazil: As deaths in the country from the coronavirus outbreak surge to the world’s highest, President Jair Bolsonaro is threatening military intervention to protect his grip on power. Political leaders and analysts say that military action remains unlikely; even so, the possibility is destabilizing the nation’s democratic institutions.

‘Gone With the Wind’: The streaming service HBO Max has removed the 1939 movie from its catalog, pledging to eventually bring the film back “with a discussion of its historical context.” Long considered a cinematic triumph, the movie has come under scrutiny for romanticizing the Civil War-era South and glossing over the horrors of slavery.

Snapshot: Above, members the Sikh Center of New York feeding protesters in Queens. The center has served more than 145,000 free meals in the past 10 weeks. It’s part of a Sikh tradition of feeding anyone in need, which has found new purpose during the coronavirus pandemic and the protests over the killing of George Floyd and police brutality.

Madeleine McCann: With a new suspect, journalists have returned to Praia da Luz, the town in Portugal where the British toddler vanished 13 years ago. Residents are wary of the attention, especially while other unresolved crimes have been archived.

What we’re looking at: This drone footage of green turtles migrating to Raine Island, the world’s largest sea turtle rookery, courtesy of The Sydney Morning Herald.

Now, a break from the news

Cook: These crispy kimchi pancakes are both satisfyingly chewy and shatteringly crisp. Use the most flavorful traditionally prepared kimchi you can find — it’ll make all of the difference in this simple recipe.

Watch: Our TV critic has some suggestions on what to watch if you’re looking for a foreign spy thriller, or simply something light. And, these movies showcase L.G.B.T.Q. characters in all of their wonderful complexity.

Behold: We asked 11 illustrators of Asian descent to create a self-portrait, reflecting on their heritage, their stories of immigration and how they identify as Asian-American.

Read: Here’s a look at down-and-out graphic novels including “The Complete Works of Fante Bukowski,” which our reviewer says is both gleefully malicious and unrepentantly stupid — a winning combination, for the most part.

We may be venturing outside, but we’re still safest inside. At Home can help make staying in tolerable, even fun, with ideas on what to read, cook, watch and do.

And now for the Back Story on …

A Syrian pharmacist’s Covid diary

Hosam al-Ali is a pharmacist in Idlib who volunteered to be the main virus-response coordinator in his region. He keeps an audio diary, which he shared day by day with our Istanbul bureau chief. Here are some of his entries on fighting a pandemic in a war zone. They have been condensed, and edited for clarity.

APRIL 5

A Day of Pain

Today I conducted training for the White Helmets [a Syrian civil defense group].

There were two teams, each with 10 people. We did two sessions to avoid crowding.

The next morning, I woke at 5 a.m., and we modified slides for the lecture. The slides outline the criteria for sending people to health facilities. They also tell people how to handle dead bodies.

The trainees from the White Helmets are very interested. Their motto, I learned, is from the Quran: “Whoever saves the life of one, it is as if he saves the life of all mankind.”

The whole day my mood was very bad, because my tooth infection had moved from my mouth to my eye, and it was very painful. I started to look like a teddy bear.

APRIL 12

The Search for a Ventilator

Yesterday a friend called me. He was looking for a ventilator for his newborn baby. All of the hospital ventilators were busy — and still we don’t have a single coronavirus case.

If that is happening, it means the medical capacity is very poor.

Today I felt depressed: I heard the baby died.

MAY 5

Pressure on All Fronts

There is something very important going on these days. It is not about the coronavirus.

It is about the people. They are in a very difficult situation. Everything is super-expensive now. The dollar is rising, and the Syrian pound is on the floor. The rate of $1 is 1,500 Syrian pounds. People are going crazy. God help the people with Ramadan, coronavirus and high prices. God help the people.

That’s it for this briefing. See you next time.

— Isabella

Thank you Carole Landry helped write this briefing. Samin Nosrat provided the recipe, and Theodore Kim and Jahaan Singh provided the rest of the break from the news. You can reach the team at briefing@nytimes.com.

P.S. • We’re listening to “The Daily.” Our latest episode is about remembering George Floyd. • Here’s today’s Mini Crossword puzzle, and a clue: Ice cream holder (three letters). You can find all our puzzles here. • Times journalists explained how they decide if scientific research is reliable for Times Insider.

Source link

قالب وردپرس

from World Wide News https://ift.tt/2AULGoP

[ramshariraut]

Alfentanil  Market: Worldwide Industry Analysis and New Market Opportunities Explored By 2028

Global Alfentanil  Market, Geography (North America (United States, Canada and Mexico), South America (China, Japan, Korea, India and Southeast Asia), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), Middle East and Africa (Saudi Arabia, Egypt, Nigeria and South Africa)) Industry Trends 2021-2028

<strong>Market overview</strong> This market report on Alfentanil   can help the companies to make crucial business plans on production techniques, raw materials procurement, and to increase the industry chain cycle of the market globally. The case study report on Alfentanil   is a brief history and a detailed assessment of the Alfentanil   market 2021 including key company profiles, and overall competitive scenario, key market trends, upcoming technologies, industry drivers, challenges, regulatory policies.

<strong> Request a sample Report of Alfentanil  Market @ <a href=https://www.statistifymarketresearch.com/reports/alfentanil-market/sample-request-82956>https://www.statistifymarketresearch.com/reports/alfentanil-market/sample-request-82956</a></strong>

<strong>Methodology</strong> The research work involved the usage of both primary and secondary data sources. The research methods involved the study of many points affecting the industry, including government guidelines, market surroundings, combative landscape, past data. Primary and Secondary research are the two methods that are used for the survey purpose. The primary sources consist of having interviews with many industry experts, suppliers, and other specialists. The secondary sources consist of an analysis of empirical data from press releases, government-designed websites, yearly reports of the companies, and other related documents. Other fields of the examination are modern shifting in the market, technological invention, upcoming technologies, and the technical enhancement in related industries, market risks, opportunities, hindering, and risks in the operating market. The Data acquirement phase involves gathering and merging market information and data related with the help of various sources and research processes. Structured databases such as D&B Hoover and Bloomberg are used which helps to recognize the competitive environment of top market players along with profile details.

<strong>Regional Analysis</strong> Any type of report on Alfentanil   is a highly valuable and important tool for any business association regardless of the scale on which it operates in the sector. It provides a source to track and examine the performance and overall condition of the business while also identifying fields that has the scope for improvement for the better functioning of the organization. A well-prepared business report also holds great value as it suggests preventive measures that need to be done to avoid the business fails to meet the desired targets and thus helps to recover from the adversities. An annual report on Alfentanil   prepared in the company is an effective tool for providing employees, investors, and other clients with a complete picture of their business.

<strong>Customization of the Report: </strong> The customized report is provided by our consultancy at a reasonable price. We provide updated information according to the requirements of the customers in the market world.

<strong>Top Listed Companies in the Alfentanil  Market Include</strong>

Akorn,CristÁLia,JV Healthcare,Pfizer,Johnson & Johnson,Hameln Pharmaceuticals,Horizon Hospital Healthcare,Angelini Pharma,Novartis,Auden Mckenzie,Algol Pharma,Max Health

<strong>Reasons to buy this Report:</strong> It helps in understanding the major key product segments. This report throws on Alfentanil   light on the dynamics of the market such as drivers, restraints, trends, and opportunities. It offers the regional analysis of Alfentanil   Market along with business profiles of several stakeholders in the research market. It offers massive data about trending factors that will influence the progress of the Alfentanil   Market. It offers an in-depth analysis of the changing competitive scenario in the Alfentanil   market of the research industry.

<strong>Request for Customization @ <a href=https://www.statistifymarketresearch.com/checkout/?currency=USD&type=single_user_license&report_id=82956>https://www.statistifymarketresearch.com/checkout/?currency=USD&type=single_user_license&report_id=82956</a></strong>

<strong>Benefits:</strong> 1. Well updated information. 2. Statistical report provided. 3. Discount offer in customization. 4. Service at the global level. 5. Company research report provided.

<strong>Services:</strong> 1. Expert analysts at your service. 2. Service according to your needs 3. Clearance of your queries. 4. Whole day service 5. Well updated Report.

<strong>Frequently Asked Questions?</strong> Q1. What is the total market value of the Alfentanil  market report? Q2. What would be the forecast period in the Alfentanil  market report? Q3. What is the base year considered in the Alfentanil   market report? Q4. Which are the top companies hold the market share in the Alfentanil   market ? Q5. Which is expected to be the fastest growing segment in the Alfentanil   market? Q6. Which market holds the maximum market share of the Alfentanil   market ? Q7. How the company profile has been selected? Q8. What will be the market value of the Alfentanil  market in 2028?

<strong>Full Report Summary of Alfentanil  Market @ <a href=https://www.statistifymarketresearch.com/alfentanil-market>https://www.statistifymarketresearch.com/alfentanil-market</a></strong>

<strong>About Statistify Market Research</strong> Statistify Market Research is a market research organization that endeavors to furnish all clients with the most ideal help and suggestions. Our research is exceptionally intended for your associations working in all areas and assist them with investigating viable development techniques and proposals. We don't hold fast to a uniform rule. We comprehend that your organization has explicit research necessities, and we endeavor to comprehend the subtleties of your individual research needs so we can give you concentrated research administrations.

<strong>Company Name - Statistify Market Research</strong> Office Address - 156, Sector 9 Vasundhra Aptts Rohini, New Delhi 110085 IN Telephone Numbers - (+44) 162-237-1047 (+44) 162-237-1047 Email ID - <a href="mailto:sales@statistifymarketresearch.com"><strong>sales@statistifymarketresearch.com</strong></a> Contact Us – <a href="https://www.statistifymarketresearch.com/contact-us/"><strong>https://www.statistifymarketresearch.com/contact-us/</strong></a>

[lisaoshiola]

Heart diseases and issues in children under 18 years old, while not prevalent, are increasing rapidly in the nation today.

[satyathemehta]

NATIONAL ELIGIBILITY CUM ENTRANCE TEST - UG (NEET 2018)

NATIONAL ELIGIBILITY CUM ENTRANCE TEST – UG (NEET 2018)

IMPORTANT DATES OF NEET (UG) 2018

Schedule for on-line submission of application 08.02.2018 (Thursday) to 09.03.2018 (Friday) upto 23:50 Hrs. (IST)

Schedule for successful payment of online fee 08.02.2018 (Thursday) to 10.03.2018 (Saturday) upto 23:50 Hrs. (IST)

Correction in Application Form 12.03.2018 (Monday) to 16.03.2018 (Friday)

Date of uploading of Admit Cards on website 2nd Week of April,…

[neurosurgeondelhi]

Neurosurgeon in India.

Dr. V K Jain is the Principal Director of Neurosurgery and Spine Surgery at Max Hospitals in Delhi and NCR.

Dr. Vijender Kumar Jain is one of the best neurosurgeons and spine surgeons in India. He is the head of Max Hospitals' Neuro and Spine Department in Delhi and NCR region. He has over 41 years of experience in Neurosurgery. He is the most recommended neurosurgeon in India by patients. He has performed over 16,000 procedures and is recognized for his expertise and skill in the field.Get an appointment with a Dr. V K Jain, Spine Surgeon/Neurosurgeon in India for Brain Tumor Surgery, Spinal instrumentation surgery, Intraventricular Tumor surgery, Cerebrovascular surgery etc. Get in touch with us for Best Spine & Neuro treatment from the Leading Neurosurgeon in India.

Dr. Vijendra Kumar Jain

Neurosurgery and Spine SurgeryOur Clinic Address

Head Office :Max Super Speciality Hospital, Saket Institutional Area, Saket, New Delhi, Delhi 110017, India

Phone :+91-099-107-74433,

Email : vkjneuro@gmail.com